Opko Health, Inc (OPK) reported earnings results for the quarter ended September 2011. Analysts were expecting $-0.03 per share, and the company reported $-0.02 per share. Actual earnings beat estimated earnings by $0.01 per share. Investors might expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. A total of 1 analyst is currently covering this company. Shares of OPK fell by 0.21% or $-0.01/share to $4.84. In the past year, the shares have traded as low as $3.15 and as high as $5.85. On average, 1719790 shares of OPK exchange hands on a given day and today's volume is recorded at 45580.
Aspenbio Pharma, Inc (APPY) announced their most recent earnings results for the quarter ended in September 2011. Earnings came in at $-0.38 per share compared to analyst estimates of $-0.4 per share. Earnings were 5.0% larger than expected. An upside surprise. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. There is currently 1 analyst covering this firm. Investors can look to their reports for more information. Shares of APPY fell by 5.98% or $-0.07/share to $1.10. In the past year, the shares have traded as low as $1.00 and as high as $4.85. On average, 25065 shares of APPY exchange hands on a given day and today's volume is recorded at 15805.
Golar Lng Partners Lp (GMLP) announced their most recent earnings results for the quarter ended in September 2011. Analysts were expecting $0.42 per share, and the company reported $0.35 per share. Earnings were unexpectedly -16.67% lower or $-0.07 per share below estimates. Investors could expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. A total of 4 analysts are currently covering this company.
Regenerx Biophm (RGRX) announced their most recent earnings results for the quarter ended in September 2011. The company reported $-0.03 per share when analysts were expecting earnings of $-0.02. Earnings missed estimates by an unexpected -50.0% downside surprise. Investors might expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. There is currently 1 analyst covering this firm. Investors can look to their reports for more information.
Oxis Intl Inc (OXIS) announced their most recent earnings results for the quarter ended in September 2011. Analysts were expecting $0.0 per share, and the company reported $0.0 per share. Actual earnings met the estimated earnings per share. Investors could expect the stock price to remain stable based on this news of earnings meeting expectations. Guidance, current stock price, and revenue estimates must be considered for stock price direction. A total of 1 analyst is currently covering this company.
